S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Artelo Biosciences (ARTLW) News Today

$0.02
0.00 (0.00%)
(As of 04/17/2024 ET)
SourceHeadline
uk.investing.com logoArtelo Biosciences Inc (ARTL)
uk.investing.com - March 28 at 12:13 AM
markets.businessinsider.com logoBuy Rating on Artelo Biosciences: Strong Pipeline and Market Potential
markets.businessinsider.com - March 27 at 8:49 AM
investorplace.com logoARTL Stock Earnings: Artelo Biosciences Misses EPS for Q4 2023
investorplace.com - March 25 at 3:36 PM
benzinga.com logoRecap: Artelo Biosciences Q4 Earnings
benzinga.com - March 25 at 1:13 PM
finance.yahoo.com logoArtelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
finance.yahoo.com - March 12 at 10:05 AM
finance.yahoo.com logoArtelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th
finance.yahoo.com - February 15 at 9:21 AM
finance.yahoo.com logoArtelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
finance.yahoo.com - January 23 at 8:47 AM
finance.yahoo.com logoArtelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
finance.yahoo.com - November 30 at 12:54 PM
finance.yahoo.com logoArtelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
finance.yahoo.com - November 9 at 1:03 PM
finance.yahoo.com logoPrincipal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia
finance.yahoo.com - October 4 at 8:58 AM
finance.yahoo.com logoArtelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
finance.yahoo.com - September 13 at 10:33 AM
finance.yahoo.com logoArtelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12
finance.yahoo.com - September 7 at 7:04 PM
finance.yahoo.com logoArtelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th
finance.yahoo.com - September 6 at 9:32 AM
finance.yahoo.com logoArtelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - August 10 at 9:42 AM
finance.yahoo.com logoArtelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
finance.yahoo.com - July 19 at 10:39 AM
finance.yahoo.com logoArtelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11
finance.yahoo.com - July 10 at 8:38 AM
finance.yahoo.com logoArtelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
finance.yahoo.com - June 28 at 9:52 AM
msn.com logoArtelo Biosciences Presents Groundbreaking Research At Annual CBD Symposium In Canada
msn.com - June 26 at 11:12 PM
finance.yahoo.com logoArtelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium
finance.yahoo.com - June 26 at 12:55 PM
finance.yahoo.com logoArtelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society Symposium
finance.yahoo.com - June 7 at 12:41 PM
finance.yahoo.com logoArtelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
finance.yahoo.com - March 31 at 9:19 AM
finance.yahoo.com logoArtelo Biosciences Completes Enrollment of the Phase 1b Stage of its CAReS Clinical Trial Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
finance.yahoo.com - February 2 at 10:33 AM
finance.yahoo.com logoArtelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd
finance.yahoo.com - January 26 at 10:33 AM
uk.finance.yahoo.com logoArtelo Biosciences, Inc. (ARTLW)
uk.finance.yahoo.com - September 1 at 11:54 PM
marketwatch.com logoArtelo Biosciences Shares Up on Promising Antianxiety Research
marketwatch.com - August 16 at 12:39 PM
finance.yahoo.com logoArtelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 8:25 AM
finance.yahoo.com logoArtelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
finance.yahoo.com - July 19 at 10:54 AM
finance.yahoo.com logoeFFECTOR Therapeutics, Inc. (EFTRW)
finance.yahoo.com - July 14 at 11:13 PM
finance.yahoo.com logoArtelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Ireland
finance.yahoo.com - June 24 at 8:51 AM
benzinga.com logoArtelo Biosciences (NASDAQ:ARTLW), Short Interest Report
benzinga.com - June 13 at 10:55 PM
finance.yahoo.com logoArtelo Biosciences to Present at the LD Micro Invitational XII on June 7th
finance.yahoo.com - June 1 at 9:58 AM
finance.yahoo.com logoArtelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th
finance.yahoo.com - May 13 at 4:38 PM
finance.yahoo.com logoArtelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - May 12 at 10:57 AM
Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ARTLW Media Mentions By Week

ARTLW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARTLW
News Sentiment

0.00

0.39

Average
Medical
News Sentiment

ARTLW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARTLW Articles
This Week

0

0

ARTLW Articles
Average Week

Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ARTLW) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners